Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2026-02-21 @ 9:24 PM
Study NCT ID:
NCT02395692
Status:
TERMINATED
Last Update Posted:
2019-04-04
First Post:
2015-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-23
First Submit QC Date:
None
Study First Post Date:
2015-03-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-28
Results First Submit QC Date:
None
Results First Post Date:
2019-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-14
Last Update Post Date:
2019-04-04
Last Update Post Date Type:
ACTUAL